VERA
VERA
NASDAQ · Biotechnology

Vera Therapeutics Inc

$34.00
-0.27 (-0.79%)
As of Sep 21, 1:21 PM ET ·
Analyst Consensus
Strong Buy
20
Analysts
High
Coverage
Buy 18 90%
Hold 2 10%
Sell 0 0%
Price Target
Analyst Price Target +178.3% upside
Low Target $72.50
Average Target $94.61
High Target $144.94
Current Price $34.00
Current
$34.00
Target
$94.61
$72.50 $94.61 avg $144.94
Scenario Analysis
Bear Case
$72.50
113.2%
Low target
Base Case
$94.61
+178.3%
Avg target
Bull Case
$144.94
+326.3%
High target
Risk/Reward
2.9x
Favorable
Price in Context
52-Week High
$56.05
-39.3% from high
52-Week Low
$23.05
+47.5% from low
50-Day SMA
$46.91
-27.5% vs SMA
200-Day SMA
$30.68
+10.8% vs SMA
RSI (14)
41.5
Neutral
Target vs 52W High
$94.61
+68.8% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Strong Buy 39 82% $257.58 -2.6%
AMGN
Amgen Inc
Hold 43 47% $190.87 -51.5%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +140.9%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 36 81% $438.34 -14.2%
REGN
Regeneron Pharmaceuticals
Buy 38 68% $76.80 -90.4%
MRNA
Moderna Inc
Hold 30 37% $149.45 -13.6%
NTRA
Natera Inc
Strong Buy 30 87% $142.91 -61.4%
RVMD
Revolution Medicines Inc
Strong Buy 28 93% $114.11 -40.8%